Schedule 13G Filing by Parian Ultreia LP for Neuronetics, Inc.

Parian Ultreia LP, a Delaware entity, has filed a Schedule 13G, reporting beneficial ownership of 4,844,908 shares of Neuronetics, Inc. common stock, representing 7.0% of the class. This ownership was acquired on March 17, 2026. The filing states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, nor in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.